Answers are grounded in this paper and cite their sources.
Identifies asthma clusters in aspirin-hypersensitive patients, suggesting targeted therapies may be necessary.
Background Up to 50% of patients with nonsteroidal anti‐inflammatory drug‐exacerbated respiratory disease (N‐ERD) exhibit a noneosinophilic airway inflammatory phenotype, with paucigranulocytic asthma being the most prevalent. The aim was to identify clusters within N‐ERD and aspirin‐tolerant asthma (ATA) controls with a paucigranulocytic asthma phenotype. Methods Two separate hierarchical cluster analyses were performed using 23 variables in 36 N‐ERD patients and 19 ATA controls. Variables included demographic, clinical, treatment‐related, and hematologic parameters; sputum cytology; sinus computed tomography findings; and eicosanoid levels in induced sputum supernatant (ISS) and urine. Results Two clusters were identified in each group: 1 N‐ERD , 2 N‐ERD , 1 ATA , and 2 ATA . Cluster 1 N‐ERD patients had less severe asthma and required lower doses of inhaled corticosteroids (ICS) but showed higher blood eosinophil counts, Lund‐Mackay (LM) scores, and ISS leukotriene E 4 (LTE 4 ) levels than those in cluster 2 N‐ERD . Cut‐off values defining a T2‐high paucigranulocytic asthma profile in N‐ERD included LM score ≥ 18, blood eosinophils ≥ 300 cells/mm 3 , and ISS LTE 4 ≥ 30 pg/mL, with the LM score demonstrating the highest AUC at 0.8. Among ATA controls, cluster 1 ATA had more severe asthma, higher ICS doses, more severe sinonasal disease, and increased ISS leukotriene D 4 and LTE 4 levels compared with cluster 2 ATA . Conclusion Two clusters were identified among N‐ERD patients with a paucigranulocytic asthma phenotype. Cluster 1 N‐ERD was characterized by milder asthma, more severe sinonasal disease, elevated blood eosinophil counts, and elevated ISS LTE 4 . This T2‐high‐like cluster may represent a subgroup requiring further evaluation for anti‐T2 biologic therapy targeting chronic rhinosinusitis with nasal polyps, although further validation is required.
No takes yet. Share an insight, caveat, or question.
Kacorzyk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: